Purchase Order FA864925P0001
- Not listed
- This is a $108,186 Small Business Technology Transfer (STTR) Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Autonomus Medical Technologies, Inc., a for-profit small business in Cambridge, MA. The contract is for the development of a handheld robotic medical device to enable semi-automated administration of nerve blocks in austere environments. This specialized medical device is intended to empower non-specialist personnel to perform complex medical procedures in...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Air Force Research Laboratory to Autonomus Medical Technologies, Inc. for the "ENABLING RAPID TREATMENT OF NONCOMPRESSIBLE HEMORRHAGE BY A NON-SPECIALIST IN AUSTERE ENVIRONMENTS USING THE ARTIFICIAL INTELLIGENCE GUIDED ULTRASOUND INTERVENTION DEVICE (AI-GUIDE)" project. The firm-fixed-price contract has a ceiling value of $74,134.00 and a period of performance through August 7, 2023. The contract...
- The Air Force awarded a definitive contract to Amsel Medical Corporation for non-surgical control of junctional and non-compressible hemorrhage via percutaneously delivered adjustable vessel occlusion on September 30, 2024, with a ceiling value of $5,510,840.58. The contract is priced cost-plus-fixed-fee with no set-aside category. Place of performance is East Cambridge, MA. The ultimate completion date is April 29, 2027. Amsel Medical Corporation specializes in medical device research and...
- This federal contract award to Medical Technology Enterprise Consortium (MTEC), a nonprofit medical technology accelerator, is for two research projects: "ACME: The Autonomous Communications Medical Ecosystem" and "Medical Wearable Audio Video Entry (M-WAVE) Sensor Suite." The contract, awarded by the Defense Health Agency, is a $1,635,305.28 Other Transaction Order with no set-aside designation. The contract supports the development of innovative medical technologies for the...
- This federal contract award from the Defense Health Agency (DHA) is a Small Business Innovation Research (SBIR) Phase I purchase order to Advanced Life Technologies, LLC for the "ROBOMEDIC" medical research project. The firm-fixed-price contract has a ceiling value of $249,900.26 and an ultimate completion date of May 6, 2025. As an SBIR Phase I award, this contract supports early-stage research and development efforts. The contract is designated as a total small business set-aside,...
- The Department of the Air Force Materiel Command Research Laboratory awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Securisyn Medical, LLC, a self-certified small disadvantaged business. The $158,000.00 firm fixed price contract is for research and development related to oxygen delivery systems and endotracheal tube securement products to prevent dislodgement among battlefield airmen. Securisyn Medical has previously provided research, development, testing, and...
- The U.S. Air Force Research Laboratory (AFRL) awarded Code 1 Medical Devices, LLC a $1.25 million Phase II Small Business Innovation Research (SBIR) contract in August 2024 to develop advanced airway management solutions for reducing pre-hospital mortality among warfighters experiencing airway obstructions. This small business set-aside contract, structured as a firm fixed-price purchase order, represents the continuation of Code 1 Medical Devices' ongoing innovation efforts in pre-hospital...
- This is a Definitive Contract awarded by the Defense Health Agency (DHA) to Triton Systems, Inc. under the Small Business Innovation Research (SBIR) Program. The contract is for the "Automated Vascular Access in Trauma Patients" research and development project, which is a Phase II SBIR effort. The total potential value of the contract is $999,936.87, and it was awarded on a Firm Fixed Price basis. The contract has a small business set-aside designation, with Triton Systems serving...
- This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the Department of the Army Medical Command to Creare LLC, a research and development company based in Hanover, New Hampshire. The contract, valued at $149,963.38, is for the "Development of an Automated Vascular Access Device" and was set aside for small businesses. Creare has extensive experience supporting U.S. federal agencies through prime and subcontract awards, particularly in the areas of...
- This is a $2,456,062.54 Definitive Contract awarded by the Research, Development and Engineering Command (RDECOM) of the U.S. Army to Vecna Technologies, Inc., a woman-owned small business, for the HEMISPHERIC IMAGING SYSTEM SBIR PHASE II research and development effort. The contract has a firm fixed price pricing type and a period of performance through December 4, 2020. Vecna Technologies, doing business as Vecna Medical, specializes in healthcare technology solutions for federal agencies like...
The Air Force Research Laboratory awarded a $3.21 million firm fixed-price purchase order to Autonomus Medical Technologies, Inc., a Cambridge, Massachusetts-based small business specializing in medical device development for austere environments. Under this Total Small Business set-aside contract, the company will develop a semi-autonomous handheld robotic device designed to enable rapid vascular access by non-specialist medical personnel operating in resource-limited or high-stress operational settings. The contract is scheduled for completion by December 30, 2027, and represents the continuation of Autonomus Medical Technologies' existing partnership with the Air Force Research Laboratory on critical medical intervention technologies. Autonomus Medical Technologies has established a focused research portfolio with the Air Force Research Laboratory through multiple Small Business Innovation Research and Small Business Technology Transfer contracts, all designated as Total Small Business set-asides. The company's work concentrates on leveraging artificial intelligence and robotic technologies to democratize complex medical procedures, with concurrent projects addressing nerve block administration, vascular access, and hemorrhage treatment. This particular vascular access contract reflects the Air Force's investment in enabling medical capabilities that enhance operational readiness by empowering non-specialist personnel to perform sophisticated interventions in austere environments where traditional medical expertise may be unavailable.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Additional Work (new agreement, FAR part 6 applies) | $2.0m | 1/28/26 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 4/2/25 | |
| Not listed | Not listed | $1.2m | 11/8/24 |